<DOC>
<DOCNO>EP-0629401</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Use of 1,2,4-dithiazolium salts as chemotherapeutics, particularly as TNF-inhibitors, and now 1,2,4-dithiazolium salts.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3140	A61K3140	A61K3141	A61K3141	A61K3144	A61K3144	A61K31445	A61K31445	A61K31495	A61K31495	A61K31535	A61K31535	A61K3155	A61K3155	A61P900	A61P900	A61P4300	A61P4300	C07D28500	C07D28500	C07D28501	C07D41700	C07D41704	C07D41712	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P9	A61P9	A61P43	A61P43	C07D285	C07D285	C07D285	C07D417	C07D417	C07D417	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to the use of 1,2,4-dithiazolium salts of the general formula (I), some of which are known, 
<
IMAGE
>
 in which the substituents have the meanings stated in the description, to a process for their preparation and to their use as chemotherapeutics, in particular as TNF inhibitors.
 
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
</TEXT>
</DOC>
